Description

(3S,3aS,15S)-3,3a,6,7,8,9,10,11,12,13,14,15-Dodecahydro-3-(4-hydroxyphenyl)-4H-1,16-etheno-5,15-(propaniminoethano)furo[3,4-l][1,5,10]triazacyclohexadecine-4,21-dione is a complex, high-purity heterocyclic compound with a defined stereochemistry, serving as a critical advanced intermediate in modern synthetic chemistry. Its intricate fused-ring structure makes it a valuable building block for the development of novel active pharmaceutical ingredients (APIs) and specialized fine chemicals. This compound is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the synthesis of complex molecules for therapeutic applications.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the research and development of new drug candidates, particularly for complex target molecules.
• Chemical Research: Serves as a sophisticated building block in academic and industrial laboratories for exploring new chemical reactions and synthesizing novel heterocyclic compounds.
• Fine Chemical Synthesis: Used in the multi-step synthesis of high-value specialty chemicals requiring precise stereochemical control.
• API Development: Integral component in the synthetic pathways for potential Active Pharmaceutical Ingredients, especially in oncology and neurology research areas.
• Process Chemistry: Employed in scale-up studies and optimization of synthetic routes for complex organic molecules.

Basic Information

Item	Details
Product Name	(3S,3aS,15S)-3,3a,6,7,8,9,10,11,12,13,14,15-Dodecahydro-3-(4-hydroxyphenyl)-4H-1,16-etheno-5,15-(propaniminoethano)furo[3,4-l][1,5,10]triazacyclohexadecine-4,21-dione
CAS No.	69721-57-9
Molecular Formula	C28H33N3O4
Molecular Weight	475.58 g/mol
Synonyms	Furo[3,4-l][1,5,10]triazacyclohexadecine-4,21-dione derivative; 69721-57-9; (3S,3aS,15S)-Dodecahydro-3-(4-hydroxyphenyl)-4H-1,16-etheno-5,15-(propaniminoethano)furotriazacyclohexadecinedione; Complex Fused Triaza Macrocycle; Advanced Pharmaceutical Intermediate; Stereospecific Heterocyclic Building Block
EINECS	Contact for details

Quality Control

Our (3S,3aS,15S)-3,3a,6,7,8,9,10,11,12,13,14,15-Dodecahydro-3-(4-hydroxyphenyl)-4H-1,16-etheno-5,15-(propaniminoethano)furo[3,4-l][1,5,10]triazacyclohexadecine-4,21-dione is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and chiral analysis to confirm stereochemical integrity, ensuring it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) documenting identity, purity, and impurity profile is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.